{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:23Z","timestamp":1786982243697,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970533"],"award-info":[{"award-number":["81970533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022ZD21"],"award-info":[{"award-number":["ZR2022ZD21"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transjugular intrahepatic portosystemic shunt (TIPS) is recommended for treating recurrent and refractory ascites. However, determining the target portal pressure gradient (PPG) has been inconclusive. This multicentre cohort study explored the post-TIPS PPG potential range associated with improving survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study enrolled 276 patients, all of whom underwent covered TIPS for ascites treatment across four medical centers. The cumulative incidences of clinical outcomes were compared among groups categorized by potential PPG thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the whole follow-up period with a medium follow-up of 21.6 (7.5, 41.6) months, 122 (44.2%) experienced liver-related death, and 73 (26.4%) patients experienced a recurrence of ascites. Multivariable analysis revealed PPG\u2009&lt;\u20097\u00a0mmHg (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) and the recurrence of ascites (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033) are independent risk factors for survival, while the PPG\u2009\u2265\u200911\u00a0mmHg was an independent risk factor for the recurrence of ascites (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012). Patients with\u2009\u2265\u20097\u00a0mmHg had a lower rate of liver-related death than patients with post-TIPS PPG\u2009&lt;\u20097\u00a0mmHg (51.0% vs 66.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), while those with post-TIPS PPG\u2009\u2265\u200911\u00a0mmHg exhibited a higher cumulative incidence of ascites compared to those with post-TIPS PPG\u2009&lt;\u200911\u00a0mmHg (44.6% vs 33.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023). The robustness of the results was confirmed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study highlighted the existence of an optimal post-TIPS PPG range in patients with recurrent and refractory ascites. Patients may experience improved survival and ascites control with a post-TIPS PPG of 7\u201311\u00a0mmHg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-024-10742-x","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T11:58:26Z","timestamp":1731153506000},"page":"199-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimal threshold of portal pressure gradient for patients with ascites after covered TIPS: a multicentre cohort study"],"prefix":"10.1007","volume":"19","author":[{"given":"Yifu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-1579","authenticated-orcid":false,"given":"Chunqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"10742_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/hep.32596","volume":"77","author":"P Deltenre","year":"2023","unstructured":"Deltenre P, Zanetto A, Saltini D, et al. The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: recent evolution and open questions. Hepatology. 2023;77:640\u2013658","journal-title":"Hepatology"},{"key":"10742_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32596","author":"EW Lee","year":"2023","unstructured":"Lee EW, Eghtesad B, Garcia-Tsao G, et al. AASLD practice guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology. 2023. https:\/\/doi.org\/10.1002\/hep.32596","journal-title":"Hepatology"},{"issue":"69","key":"10742_CR3","first-page":"406","volume":"2018","author":"European Association for the Study of the Liver. Electronic address EEE European Association for the Study of the L","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address EEE European Association for the Study of the L. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;2018(69):406\u2013460","journal-title":"J Hepatol"},{"key":"10742_CR4","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","volume":"32","author":"A Zipprich","year":"2012","unstructured":"Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407\u20131414","journal-title":"Liver Int"},{"key":"10742_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK, et al. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51:1675\u20131682","journal-title":"Hepatology"},{"key":"10742_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","volume":"129","author":"G D'Amico","year":"2005","unstructured":"D\u2019Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282\u20131293","journal-title":"Gastroenterology"},{"key":"10742_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology. 2017;152:157\u2013163","journal-title":"Gastroenterology"},{"key":"10742_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u2013974","journal-title":"J Hepatol"},{"key":"10742_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2020.09.018","volume":"74","author":"J Bosch","year":"2021","unstructured":"Bosch J. Small diameter shunts should lead to safe expansion of the use of TIPS. J Hepatol. 2021;74:230\u2013234","journal-title":"J Hepatol"},{"key":"10742_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","volume":"114","author":"M Casado","year":"1998","unstructured":"Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296\u20131303","journal-title":"Gastroenterology"},{"key":"10742_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/hep.32676","volume":"77","author":"A Queck","year":"2023","unstructured":"Queck A, Schwierz L, Gu W, et al. Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS. Hepatology. 2023;77:466\u2013475","journal-title":"Hepatology"},{"key":"10742_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s12072-023-10489-x","volume":"17","author":"Y Xia","year":"2023","unstructured":"Xia Y, Tie J, Wang G, et al. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS. Hepatol Int. 2023;17:967\u2013978","journal-title":"Hepatol Int"},{"key":"10742_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10536-7","author":"V Singh","year":"2023","unstructured":"Singh V, De A, Mehtani R, et al. Asia-Pacific association for study of liver guidelines on management of ascites in liver disease. Hepatol Int. 2023. https:\/\/doi.org\/10.1007\/s12072-023-10536-7","journal-title":"Hepatol Int"},{"key":"10742_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","volume":"25","author":"P Deltenre","year":"2005","unstructured":"Deltenre P, Mathurin P, Dharancy S, et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int. 2005;25:349\u2013356","journal-title":"Liver Int"},{"key":"10742_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology. 2014;60:715\u2013735","journal-title":"Hepatology"},{"key":"10742_CR16","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.cgh.2015.06.039","volume":"13","author":"KR Patidar","year":"2015","unstructured":"Patidar KR, Bajaj JS. Covert and overt hepatic encephalopathy: diagnosis and management. Clin Gastroenterol Hepatol. 2015;13:2048\u20132061","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10742_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1148\/radiol.13120800","volume":"268","author":"S Chen","year":"2013","unstructured":"Chen S, Li X, Wei B, et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology. 2013;268:900\u2013906","journal-title":"Radiology"},{"key":"10742_CR18","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jvir.2008.07.021","volume":"19","author":"JJ Pan","year":"2008","unstructured":"Pan JJ, Chen C, Caridi JG, et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years\u2019 experience from a single tertiary medical center. J Vasc Interv Radiol. 2008;19:1576\u20131581","journal-title":"J Vasc Interv Radiol"},{"key":"10742_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1440-1746.2006.04697.x","volume":"23","author":"HH Chung","year":"2008","unstructured":"Chung HH, Razavi MK, Sze DY, et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol. 2008;23:95\u2013101","journal-title":"J Gastroenterol Hepatol"},{"key":"10742_CR20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5152\/dir.2014.13415","volume":"20","author":"A Parvinian","year":"2014","unstructured":"Parvinian A, Bui JT, Knuttinen MG, et al. Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites. Diagn Interv Radiol. 2014;20:58\u201364","journal-title":"Diagn Interv Radiol"},{"key":"10742_CR21","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/S0002-9270(01)03902-8","volume":"96","author":"M Rossle","year":"2001","unstructured":"Rossle M, Siegerstetter V, Olschewski M, et al. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol. 2001;96:3379\u20133383","journal-title":"Am J Gastroenterol"},{"key":"10742_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469\u2013475","journal-title":"Gastroenterology"},{"key":"10742_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jgh.12725","volume":"30","author":"HK Tan","year":"2015","unstructured":"Tan HK, James PD, Sniderman KW, Wong F. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion. J Gastroenterol Hepatol. 2015;30:389\u2013395","journal-title":"J Gastroenterol Hepatol"},{"key":"10742_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;74:1014\u20131048","journal-title":"Hepatology"},{"key":"10742_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/liv.13615","volume":"38","author":"T Bucsics","year":"2018","unstructured":"Bucsics T, Hoffman S, Grunberger J, et al. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis. Liver Int. 2018;38:1036\u20131044","journal-title":"Liver Int"},{"key":"10742_CR26","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.14309\/ajg.0000000000001357","volume":"116","author":"JR Boike","year":"2021","unstructured":"Boike JR, Mazumder NR, Kolli KP, et al. Outcomes after TIPS for ascites and variceal bleeding in a contemporary Era-An ALTA group study. Am J Gastroenterol. 2021;116:2079\u20132088","journal-title":"Am J Gastroenterol"},{"key":"10742_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100829","volume":"5","author":"AF Ehrenbauer","year":"2023","unstructured":"Ehrenbauer AF, Schneider H, Stockhoff L, et al. Predicting overt hepatic encephalopathy after TIPS: value of three minimal hepatic encephalopathy tests. JHEP Rep. 2023;5: 100829","journal-title":"JHEP Rep"},{"key":"10742_CR28","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00270-023-03593-w","volume":"46","author":"O Ince","year":"2023","unstructured":"Ince O, Onder H, Gencturk M, et al. Machine learning insights: predicting hepatic encephalopathy after TIPS placement. Cardiovasc Intervent Radiol. 2023;46:1715\u20131725","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10742-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10742-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10742-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:45:01Z","timestamp":1740210301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10742-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10742"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10742-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted following the Declaration of Helsinki, approved by the Biomedical Research Ethics Committee of Shandong Provincial Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent in studies with human subjects"}}]}}